Publications
-
Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue-Meda M, Pont-Martí S, Rives-Solà S and Camós-Guijosa M.
Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases
BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Number of citations: 12
-
Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.
Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening
PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Number of citations: 8
-
Alonso-Saladrigues A, Trenchs-Sainz de la Maza V, Payeras J and Luaces-Cubells C.
Revisión y evaluación de las maniobras de reanimación cardiopulmonar en un servicio de urgencias
Acta Pediátrica Española . 72(8): 280-284.
-
Ortiz-Maldonado V, Galimard JE, Ottaviano G, Alonso-Saladrigues A, Farhan S, Vuyyala S, Michel E, Imran F, Sánchez-Sierra N, Martínez-Cibrian N, Ryhänen SJ, Mitchell R, Mielke S, Petersen SL MD, Teyssier AC, Pabst T, Kuball J, Barba P, Pérez-Martínez A, Attarbaschi A, Nagler A, Pérez-Simón JA, von Bonin M, Nicholson EK, Beauvais D, Sorà F, Paganessi M, Penack O, Castilla-Llorente C, Beguin Y, Delgado J, Rives-Solà S, Kalwak K, Ciceri F, Ruggeri A, Balduzzi AC and Giebel S.
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy.
Blood Advances . : .
